Yann Mazabraud
Corporate Officer/Principal chez RHYTHM PHARMACEUTICALS, INC.
Fortune : 1 M $ au 30/04/2024
Profil
Yann Mazabraud currently works at Rhythm Pharmaceuticals, Inc., as Executive Vice President & Head-International from 2020.
Mr. Mazabraud also formerly worked at Genzyme Corp., as General Manager-US & Head-North America from 2016 to 2017, Genzyme Therapeutics Ltd., as Head-Latin America, and Trevi Therapeutics, Inc., as Chief Commercial Officer & Head-International from 2017 to 2020.
Mr. Mazabraud received his graduate degree from Groupe de Sup de Co La Rochelle.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/04/2024 | 34 870 ( 0,06% ) | 1 M $ | 30/04/2024 |
Postes actifs de Yann Mazabraud
| Sociétés | Poste | Début |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05/10/2020 |
Anciens postes connus de Yann Mazabraud
| Sociétés | Poste | Fin |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 03/10/2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2017 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Yann Mazabraud
| Groupe de Sup de Co La Rochelle | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |